AMERIPRISE FINANCIAL INC
Position in CRL — Charles River Laboratories International, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in CRL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$191,369,256
-$84,787,462 QoQ
Shares Held
1,109,387
-19.9% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 97.50988609024624.ToString("F0")%
None 2.4901139097537652.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $3,145,181,729 across 32 Diagnostics & Research names. CRL ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,670,400 | $821,051,708 | |
| 2 | DHR |
Danaher Corp /De/
|
3,041,408 | $576,650,954 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,624,321 | $277,011,701 | |
| 4 | WAT |
Waters Corp /De/
|
695,644 | $207,162,780 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,109,387 | $191,369,256 | |
| 6 | DGX |
Quest Diagnostics Inc
|
807,477 | $158,249,338 | |
| 7 | ILMN |
Illumina, Inc.
|
1,155,973 | $142,485,227 | |
| 8 | A |
Agilent Technologies, Inc.
|
1,204,289 | $137,264,856 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $191,369,256 | 1,109,387 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $276,156,718 | 1,384,383 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $96,004,480 | 613,604 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,851,465 | 38,565 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,007,055 | 544,825 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $41,172,442 | 223,036 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,991,834 | 213,189 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $74,750,764 | 361,849 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $76,607,316 | 282,736 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,575,491 | 23,585 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,899,890 | 25,002 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,943,395 | 23,512 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,484,640 | 22,221 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $69,400,494 | 318,497 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,649,458 | 18,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,203,865 | 19,647 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,572,341 | 26,666 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,349,390 | 27,468 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $107,049,896 | 259,408 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $311,114,185 | 841,031 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $263,312,002 | 908,505 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $287,315,760 | 1,149,907 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $172,455,713 | 761,562 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $54,667,441 | 313,550 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $39,271,503 | 311,160 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||